TUTONE, Marco
TUTONE, Marco
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
3D-QSAR Pharmacophore Modeling and in Silico Screening of new Bcl-xl Inhibitors
2010-01-01 Almerico, AM; Tutone, M; Lauria, A
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings
2020-01-01 Tutone M.; Culletta G.; Livecchi L.; Almerico A.M.
A dynamic multiple receptor conformations (MD-MRC) approach to enhance early enrichment in virtual screening. A case study on PPAR-alpha
2016-01-01 Perricone, U; Wieder, M; Seidel, T; Langer, T; Almerico, AM; Tutone, M.
A dynamic-common pharmacophore approach to improve virtual screening. A case study on PPAR-alpha
2016-01-01 Perricone, U; Almerico, AM; Tutone, M.
A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α
2017-01-01 Perricone, U.; Wieder, M.; Seidel, T.; Langer, T.; Padova, A.; Almerico, A.; Tutone, M.
A Multivariate Analysis of HIV-1 Protease Inhibitors and Resistance Induced by Mutation
2006-01-01 ALMERICO, AM; TUTONE, M; LAURIA, A; DIANA, P; BARRAJA, P; MONTALBANO, A; CIRRINCIONE, G; DATTOLO, G
A multivariate analysis on HIV-1 protease inhibitors and resistance induced by mutation
2006-01-01 ALMERICO AM; LAURIA A; TUTONE M; DIANA P; BARRAJA P; MONTALBANO A; CIRRINCIONE G; DATTOLO G
A multivariate analysis on non-nucleoside HIV-1 reverse transcriptase inhibitors and resistance induced by mutation
2004-01-01 7ALMERICO, AM; LAURIA, A; TUTONE, M; BARRAJA, P; MONTALBANO, A; CIRRINCIONE, G; DATTOLO, G
A QSAR study investigating the potential anti-HIV-1 effect of some Acyclovir and Ganciclovir analogs
2009-01-01 Almerico, AM; Tutone, M; Lauria, A
A3 Adenosine Receptor: homology modeling and 3D-QSAR studies
2011-01-01 ALMERICO, AM; TUTONE, M; PANTANO, L; LAURIA, A
A3 adenosine receptor: Homology modeling and 3D-QSAR studies
2013-01-01 Almerico, AM; Tutone, M; Pantano, L; Lauria, A
Analisi Multivariata e Docking nello Studio degli Inibitori di HIV-1 Integrasi
2005-01-01 TUTONE M; LAURIA A; ALMERICO AM
Bcl-2 come target di farmaci antitumorali modulatori dell'apoptosi
2007-01-01 TUTONE M; LAURIA A; ALMERICO AM
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors
2020-01-01 Culletta G.; Almerico A.M.; Tutone M.
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
2021-12-11 Tutone, Marco; Almerico, Anna Maria
Computational methodologies in the discovery of inhibitors of HIV-1
2009-01-01 TUTONE, M; ALMERICO, AM; LAURIA, A
Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach
2017-01-01 Tutone, M.; Perricone, U.; Almerico, A.
Consensus modelling and molecular dynamics studies for the identification of novel telomerase inhibitors as anti-cancer agents
2018-01-01 M. tutone, A.M. Almerico
DA-Phen, a new dopamine aminoacid conjugate: in vivo testing and molecular modeling as dopaminergic modulator
2014-01-01 Tutone, M; Almerico, AM; Lauria, A; Sutera, FM; Cannizzaro, C; Giannola, LI; De Caro, V